As of July 14, 2026, aTyr Pharma, Inc. (ATYR) has a DilutionWatch DilutionScore of 39/100, rated MEDIUM dilution risk. aTyr Pharma, Inc. has a market capitalization of $53.19M, 98.05M shares outstanding, 113 institutional holders tracked. Key dilution vectors include approximately 21 months of cash runway.
Source: DilutionWatch (dilutionwatch.com) — data updated daily from SEC EDGAR filings. Not financial advice.
📊 Score Breakdown
🔄Convertible Debt—
🌦️ Dilution Forecast
🌥️
Advisory
Moderate dilution signals present
39%
🔄 Reverse Split
55%
• 50-day avg $0.74 below $1 exchange minimum
🔁 Convertible Conversion
40%
• Significant convertible debt: 19% potential dilution
• Elevated convertible risk (60/100)
💹 Market Data
Market Cap$53.19M
Shares Outstanding98.05M
Float95.61M
Cash$89.01M
Debt$5.80M
Short InterestN/A
🏛 Institutional Holdings
QoQ: ↑ 14.6% shares (2026Q1 vs prior)
113 institutional holders · 65.31M shares
#1
FMR LLC
14.71M shares
#2
FEDERATED HERMES, INC.
10.51M shares
#3
VANGUARD CAPITAL MANAGEMENT LLC
7.62M shares
📉 Short Interest
Short Interest14.51M
Days to Cover5.1
% of Float15.2%
FINRA data as of Jun 30, 2026
📁 Recent SEC Activity
xbrl
XBRL WARRANT
Jul 07, 2026
xbrl
XBRL CONVERTIBLE
Dec 31, 2015
4
INSIDER TRANSACTION
Feb 04, 2026
4
INSIDER TRANSACTION
Feb 04, 2026
4
INSIDER TRANSACTION
Feb 04, 2026
Full SEC filing analysis available with free account
→
📰 Recent News
No recent news
📋 What This Means for ATYR Shareholders
aTyr Pharma, Inc. (ATYR) has a DilutionScore of 39/100, rated Medium dilution risk. This tier indicates some dilution exposure — often an older shelf registration with remaining capacity, warrants not yet exercised, or a cash position that will require monitoring over the next several quarters. Score as of July 14, 2026.
DilutionWatch's EDGAR monitoring for ATYR shows no major active dilution programs at this time. The primary risk categories — shelf registration capacity, ATM programs, warrant overhang, and cash runway — are each within normal ranges for a company of this profile. This can change quickly if a new S-3 or Form S-1 is filed.
DilutionWatch tracks over 25 SEC filing types for ATYR in real-time, scanning EDGAR every 60 seconds. The DilutionWatch screener shows real-time score changes for ATYR alongside comparable medium-risk stocks. Not financial advice — this analysis is for informational purposes only.
Track ATYR Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking ATYR — Free
Real-time SEC alerts
DilutionScore™ tracking
No credit card required
🔬 More Research for ATYR
Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.